Nephrotic Syndrome Thromboprophylaxis With Direct Oral Anticoagulants or Vitamin K Antagonists
Introduction: Nephrotic syndrome (NS) is a pathological state of the glomerular filtration barrier associated with an increased venous and arterial thrombotic risk. Current guidelines suggest heparin-based or vitamin K antagonist (VKA) regimens for thromboprophylaxis in such patients. Although widel...
Saved in:
| Main Authors: | Edouard Cubilier, Youcef Chergui, Cyril Garrouste, Ines Ramos, Carole Philipponnet, Alba Atenza, Clarisse Greze, Julien Aniort, Charlotte Uro-Coste, Anne-Elisabeth Heng |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-05-01
|
| Series: | Kidney International Reports |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2468024925001184 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Possibilities of pharmacological thromboprophylaxis in microsurgery in real-world clinical practice
by: I. Yu. Zolotukhina, et al.
Published: (2025-04-01) -
Anticoagulation for the Prevention of Thrombotic Events in Nephrotic Syndrome
by: David Massicotte Azarniouch, et al.
Published: (2024-10-01) -
Venous Thromboembolism Prevention in Nephrotic Syndrome: The Role of Aspirin, Vitamin K Antagonists, and Direct Oral Anticoagulants
by: Zohreh Gholizadeh Ghozloujeh, et al.
Published: (2025-05-01) -
Aspirin Versus LMWH for Thromboprophylaxis Following Hip or Knee Arthroplasty—Clinical Implications and Budget Impact
by: Eugen Javor, et al.
Published: (2025-08-01) -
Primary thromboprophylaxis in ambulatory symptomatic patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials
by: Davide Di Vece, et al.
Published: (2024-11-01)